-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Intuitive Surgical, Lowers Price Target to $635

Benzinga·04/24/2025 21:20:02
Listen to the news
Barclays analyst Matt Miksic maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and lowers the price target from $684 to $635.